Néoplasie

Fr | De

Feedback | Impressum | Sitemap

Aucun choix d'articles!

Panier

Vous êtes ici: Recherche de documentation spécialisée » Pancréas » Néoplasie

02. Mai 2026

Dépistage / diagnostic

Recherche de documentation spécialisée

Écriture:

Page 1 de 2995


	Articles 1 - 20 / 59890

	Differentiating walled-off pancreatic necrosis with no documented pancreatitis from mucinous cystic neoplasms: a multicenter LASSO-based nomogram. BMC Gastroenterol Xu J, Huang X, Duan J, Chen X, Zheng X, Wang Y, Fan S, Wang W, Yu R. PMID: 42067811 [PubMed - as supplied by publisher]
	Apilimod in Oncology: From Non-Malignant Origins to Emerging Anti-Cancer Potential. Eur J Pharmacol Evrard C, Gündel B, Löhr M, Heffinger L, Heuchel R. PMID: 42067017 [PubMed - as supplied by publisher]
	Rare pathological types of gallbladder cancer: Cases report. Medicine (Baltimore) Wang H, Wang Z, Zhao Y, Xiang Y, Li J, Tuo H. PMID: 42065192 [PubMed - indexed for MEDLINE]
	Current Advances in Preclinical Patient-Derived Cultivation Models for Individualized Drug Response Prediction in Pancreatic Cancer. Oncol Res Heckelmann B, Duhn J, Braun R. PMID: 42065069 [PubMed - indexed for MEDLINE]
	Cancer-Associated Arterial Thrombosis: Mechanisms and Risk Factors. Oncol Res Lalechou K, Pantazi D. PMID: 42065044 [PubMed - indexed for MEDLINE]
	Type 2 diabetes mellitus and cancer: A systematic review and meta-analysis of Mendelian randomization studies. Front Endocrinol (Lausanne) Wu W, Huang GL, Cui J. PMID: 42064762 [PubMed - indexed for MEDLINE]
	Drug resistance mechanisms of immunotherapy and translational strategies for reversing resistance for hepatocellular carcinoma: from bench to bedside. Front Immunol Zhang C, Zhang D, Wen X, Liu S. PMID: 42064051 [PubMed - indexed for MEDLINE]
	Estimating the impact of scaling up workforce personnel on global cancer mortality from 2030 to 2050: a simulation-based analysis of 17 cancers and 18 personnel types. Lancet Oncol Ward ZJ, Moraes FY, Scott AM, Favorito FM, Ngwa W, Rebbeck TR, Gopal S, Dako F, Avery S, Loehrer PJ, Hricak H. PMID: 42061369 [PubMed - indexed for MEDLINE]
	Estimating total and diagnosed global cancer incidence and stage distribution from 1990 to 2050: a simulation-based analysis of 17 cancers. Lancet Oncol Ward ZJ, Moraes FY, Scott AM, Rebbeck TR, Loehrer PJ, Hricak H. PMID: 42061367 [PubMed - indexed for MEDLINE]
	Growth hormone receptor blockade in cancer treatment. Growth Horm IGF Res Guevara A, Kopchick J. PMID: 42061055 [PubMed - as supplied by publisher]
	Clinical use of Ankaferd Blood Stopper in wound healing: a case study of a patient with burns and pancreatic cancer. J Wound Care Díaz PP. PMID: 42060509 [PubMed - indexed for MEDLINE]
	Long-Term Outcomes of Patients With BRCA+ or PALB2+ Pancreatic Cancer Treated With Maintenance Rucaparib: A Secondary Analysis of a Nonrandomized Clinical Trial. JAMA Oncol Reiss KA, Xia M, Akamandisa M, D'Andrea K, Wubbenhorst B, Lord CJ, Pettitt SJ, Tutt ANJ, Brown TJ, O'Hara MH, Schneider C, Teitelbaum U, Hannan Z, Hood R, Tondon R, Vonderheide RH, Domchek SM, Nathanson KL. PMID: 42060271 [PubMed - as supplied by publisher]
	MET Amplification in Gallbladder Cancer: a Case Report on a Precision Medicine Approach with Glumetinib and Envafolimab. J Gastrointest Cancer Wu XJ, Nie X, Xu JF, Gui RJ, Duan HX. PMID: 42060015 [PubMed - in process]
	Mistletoe extract in patients with advanced pancreatic cancer: Health-related quality of life in a double-blind, randomized, placebo-controlled trial (MISTRAL). Palliat Med Wode K, Björ O, Klein R, Elander NO, Fransson P, Henriksson R, Sharp L, Scheibling U, Johansson B, Hök Nordberg J, Kienle GS. PMID: 42059487 [PubMed - as supplied by publisher]
	"Ferroptosis-immune" cycle: Research progress of tumor microenvironment responsive nanomaterials in the treatment of pancreatic cancer. iScience Liu Y, Bao T. PMID: 42058896 [PubMed]
	In vitro studies on curcumin-chitosan-Multiwalled Carbon Nanotubes (MWCNT) cytotoxicity against A549 (lung cancer cell line) HCT 116 (colorectal cancer cell line) and PANC1 (pancreatic cancer cell line). Toxicol Rep Rabba'a MM, Abu-Zurayk RA, Bustanji YK, Abu-Irmaileh B, Mallouh SA, Khalaf A. PMID: 42058868 [PubMed]
	Assessing the Impact of Specialist Palliative Care on Healthcare Utilisation at the End of Life Among Patients With Pancreatic Cancer: A Nationwide Register-Based Cohort Study. Cancer Med Rautakorpi L, Nåhls NS, Saarto T, Nuutinen M, Akrén O, Carpén T. PMID: 42057456 [PubMed - indexed for MEDLINE]
	Gut microbiota and pancreatic cancer: tumorigenesis, progression, and clinical applications. Cancer Biol Med Cheng C, Wang J, Xie J, Yin H, Xu Z, Xie Y, He T, Jiang Z, Wang Y, Wu W, Lou W, Wang J, Liu L, Pu N. PMID: 42057349 [PubMed - as supplied by publisher]
	Lactylation and targeted therapy resistance in hepatocellular carcinoma. Clin Epigenetics Zhu S, Tan C, Tan Q, Tan W, Tan Y. PMID: 42057126 [PubMed - as supplied by publisher]
	Impact of jaundice-induced elevated red blood cell distribution width on survival outcomes in pancreatic cancer patients: a retrospective cohort study. BMC Gastroenterol Wang H, Zhou W, Tan Y, Peng Q, Fu Z, Duan H, Miao T, Jin L. PMID: 42056933 [PubMed - as supplied by publisher]

Articles 1 - 20 / 59890

Page 1 de 2995



		Intervalle de temps demandé

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy \| Publicité